Tapewire

Nasdaq · USD

HQY

HEALTHEQUITY, INC.

Export transactions ↓
Tapewire entity
3639
SEC CIK
0001428336
Parsed reports
607

Last 12 months

Inside the activity.

0 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202602
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 19, 2017 Filed Jun 21, 2017 22:35 UTC
Medici FrankDirector
SaleCommon Stock 4,002 $51.99 $208,052.77
Disclosure

SEC source: 0001140361-17-025727 · doc1.xml · nonDerivative · entry 1

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,300,007

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.53 to $52.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 15, 2017 Filed Jun 19, 2017 22:40 UTC
Neeleman StephenDirector · Founder and Vice Chairman
Exercise / conversionStock Option (right to buy) · Derivative 1,000 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001140361-17-025511 · doc1.xml · derivative · entry 7

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 1,000 shares

Expires 2024-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F11 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
June 15, 2017 Filed Jun 19, 2017 22:40 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 1,264 $50.81 $64,220.05
Disclosure

SEC source: 0001140361-17-025511 · doc1.xml · nonDerivative · entry 6

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 268,000

F7 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.78 to $50.97, inclusive.

F9 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

Read SEC document
June 15, 2017 Filed Jun 19, 2017 22:40 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 3,736 $50.26 $187,779.21
Disclosure

SEC source: 0001140361-17-025511 · doc1.xml · nonDerivative · entry 5

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 269,264

F7 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.73 to $50.68, inclusive.

F9 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

Read SEC document
June 15, 2017 Filed Jun 19, 2017 22:40 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 575 $50.81 $29,215.23
Disclosure

SEC source: 0001140361-17-025511 · doc1.xml · nonDerivative · entry 4

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 747,785

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.76 to $50.95, inclusive.

F5 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

Read SEC document
June 15, 2017 Filed Jun 19, 2017 22:40 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 1,925 $50.28 $96,785.15
Disclosure

SEC source: 0001140361-17-025511 · doc1.xml · nonDerivative · entry 3

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 748,360

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.73 to $50.69, inclusive.

F5 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

Read SEC document
June 15, 2017 Filed Jun 19, 2017 22:40 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 1,000 $50.39 $50,394.80
Disclosure

SEC source: 0001140361-17-025511 · doc1.xml · nonDerivative · entry 2

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.97 to $50.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6), (8) and (10) to this Form 4.

Read SEC document
June 15, 2017 Filed Jun 19, 2017 22:40 UTC
Neeleman StephenDirector · Founder and Vice Chairman
Exercise / conversionCommon Stock 1,000 $14.00 $14,000.00
Disclosure

SEC source: 0001140361-17-025511 · doc1.xml · nonDerivative · entry 1

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 23:45 UTC SaleCommon Stock 210,906 $52.03 $10,973,122.82
Disclosure

SEC source: 0001140361-17-025431 · doc1.xml · nonDerivative · entry 1

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,304,009

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.99 to $52.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 23:42 UTC
Medici FrankDirector
SaleCommon Stock 210,906 $52.03 $10,973,122.82
Disclosure

SEC source: 0001140361-17-025430 · doc1.xml · nonDerivative · entry 1

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,304,009

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.99 to $52.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 13, 2017 Filed Jun 14, 2017 01:47 UTC SaleCommon Stock 1,700 $52.53 $89,301.00
Disclosure

SEC source: 0001140361-17-024918 · doc1.xml · nonDerivative · entry 6

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,514,915

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 13, 2017 Filed Jun 14, 2017 01:47 UTC SaleCommon Stock 125,474 $51.97 $6,520,545.00
Disclosure

SEC source: 0001140361-17-024918 · doc1.xml · nonDerivative · entry 5

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,516,615

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.51 to $52.41, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 13, 2017 Filed Jun 14, 2017 01:45 UTC
Medici FrankDirector
SaleCommon Stock 1,700 $52.53 $89,301.00
Disclosure

SEC source: 0001140361-17-024917 · doc1.xml · nonDerivative · entry 6

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,514,915

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 13, 2017 Filed Jun 14, 2017 01:45 UTC
Medici FrankDirector
SaleCommon Stock 125,474 $51.97 $6,520,545.00
Disclosure

SEC source: 0001140361-17-024917 · doc1.xml · nonDerivative · entry 5

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,516,615

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.51 to $52.41, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 12, 2017 Filed Jun 14, 2017 01:47 UTC SaleCommon Stock 11,313 $51.23 $579,578.57
Disclosure

SEC source: 0001140361-17-024918 · doc1.xml · nonDerivative · entry 4

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,642,089

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.46, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 12, 2017 Filed Jun 14, 2017 01:45 UTC
Medici FrankDirector
SaleCommon Stock 11,313 $51.23 $579,578.57
Disclosure

SEC source: 0001140361-17-024917 · doc1.xml · nonDerivative · entry 4

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,642,089

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.46, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 01:47 UTC SaleCommon Stock 86,965 $54.40 $4,731,235.16
Disclosure

SEC source: 0001140361-17-024918 · doc1.xml · nonDerivative · entry 3

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,653,402

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.86 to $54.64, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 01:47 UTC SaleCommon Stock 540 $53.00 $28,620.00
Disclosure

SEC source: 0001140361-17-024918 · doc1.xml · nonDerivative · entry 2

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,740,367

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 01:47 UTC SaleCommon Stock 22,359 $52.00 $1,162,668.00
Disclosure

SEC source: 0001140361-17-024918 · doc1.xml · nonDerivative · entry 1

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,740,907

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) to this Form 4.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 01:45 UTC
Medici FrankDirector
SaleCommon Stock 86,965 $54.40 $4,731,235.16
Disclosure

SEC source: 0001140361-17-024917 · doc1.xml · nonDerivative · entry 3

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,653,402

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.86 to $54.64, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 01:45 UTC
Medici FrankDirector
SaleCommon Stock 540 $53.00 $28,620.00
Disclosure

SEC source: 0001140361-17-024917 · doc1.xml · nonDerivative · entry 2

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,740,367

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 09, 2017 Filed Jun 14, 2017 01:45 UTC
Medici FrankDirector
SaleCommon Stock 22,359 $52.00 $1,162,668.00
Disclosure

SEC source: 0001140361-17-024917 · doc1.xml · nonDerivative · entry 1

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,740,907

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) to this Form 4.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 07, 2017 Filed Jun 10, 2017 01:12 UTC
Kessler JonDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 150,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001140361-17-024622 · doc1.xml · derivative · entry 3

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 150,000 shares

Expires 2021-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F3 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
June 07, 2017 Filed Jun 10, 2017 01:12 UTC
Kessler JonDirector · President and CEO
SaleCommon Stock 150,000 $50.27 $7,541,070.00
Disclosure

SEC source: 0001140361-17-024622 · doc1.xml · nonDerivative · entry 2

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,000

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 07, 2017 Filed Jun 10, 2017 01:12 UTC
Kessler JonDirector · President and CEO
Exercise / conversionCommon Stock 150,000 $1.25 $187,500.00
Disclosure

SEC source: 0001140361-17-024622 · doc1.xml · nonDerivative · entry 1

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 570,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

Read SEC document
June 07, 2017 Filed Jun 10, 2017 01:09 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 11,745 $52.45 $616,034.65
Disclosure

SEC source: 0001140361-17-024621 · doc1.xml · nonDerivative · entry 4

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 750,285

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.02 to $52.80, inclusive.

F3 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

Read SEC document
June 07, 2017 Filed Jun 10, 2017 01:09 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 6,344 $51.64 $327,572.44
Disclosure

SEC source: 0001140361-17-024621 · doc1.xml · nonDerivative · entry 3

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 762,030

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.02 to $51.96, inclusive.

F3 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

Read SEC document
June 07, 2017 Filed Jun 10, 2017 01:09 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 21,911 $50.26 $1,101,216.18
Disclosure

SEC source: 0001140361-17-024621 · doc1.xml · nonDerivative · entry 2

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 768,374

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4.

F3 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

Read SEC document
June 05, 2017 Filed Jun 8, 2017 00:00 UTC
Dreier AshleyExecutive VP, CTO and CIO
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001140361-17-024410 · doc1.xml · derivative · entry 4

Dreier Ashley · CIK 0001614957 · Executive VP, CTO and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 10,000 shares

Expires 2023-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2016, as amended on April 10, 2017.

F4 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
June 05, 2017 Filed Jun 8, 2017 00:00 UTC
Dreier AshleyExecutive VP, CTO and CIO
SaleCommon Stock 3,200 $48.24 $154,370.24
Disclosure

SEC source: 0001140361-17-024410 · doc1.xml · nonDerivative · entry 3

Dreier Ashley · CIK 0001614957 · Executive VP, CTO and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,652

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2016, as amended on April 10, 2017.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.03 to $48.62, inclusive.

Read SEC document
June 05, 2017 Filed Jun 8, 2017 00:00 UTC
Dreier AshleyExecutive VP, CTO and CIO
SaleCommon Stock 6,800 $47.61 $323,774.52
Disclosure

SEC source: 0001140361-17-024410 · doc1.xml · nonDerivative · entry 2

Dreier Ashley · CIK 0001614957 · Executive VP, CTO and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,852

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2016, as amended on April 10, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.97 to $47.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
June 05, 2017 Filed Jun 8, 2017 00:00 UTC
Dreier AshleyExecutive VP, CTO and CIO
Exercise / conversionCommon Stock 10,000 $1.50 $15,000.00
Disclosure

SEC source: 0001140361-17-024410 · doc1.xml · nonDerivative · entry 1

Dreier Ashley · CIK 0001614957 · Executive VP, CTO and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2016, as amended on April 10, 2017.

Read SEC document
June 02, 2017 Filed Jun 6, 2017 00:35 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 40,000 $48.36 $1,934,572.00
Disclosure

SEC source: 0001140361-17-023871 · doc1.xml · nonDerivative · entry 2

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 790,285

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.02 to $48.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

Read SEC document
June 01, 2017 Filed Jun 6, 2017 00:15 UTC
Kessler JonDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001140361-17-023861 · doc1.xml · derivative · entry 5

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 30,000 shares

Expires 2021-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F5 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
June 01, 2017 Filed Jun 6, 2017 00:15 UTC
Kessler JonDirector · President and CEO
SaleCommon Stock 7,529 $47.51 $357,697.52
Disclosure

SEC source: 0001140361-17-023861 · doc1.xml · nonDerivative · entry 4

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,000

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.36 to $47.95, inclusive.

Read SEC document
June 01, 2017 Filed Jun 6, 2017 00:15 UTC
Kessler JonDirector · President and CEO
SaleCommon Stock 10,481 $47.05 $493,081.79
Disclosure

SEC source: 0001140361-17-023861 · doc1.xml · nonDerivative · entry 3

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427,529

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.36 to $47.35, inclusive.

Read SEC document
June 01, 2017 Filed Jun 6, 2017 00:15 UTC
Kessler JonDirector · President and CEO
SaleCommon Stock 11,990 $45.44 $544,878.36
Disclosure

SEC source: 0001140361-17-023861 · doc1.xml · nonDerivative · entry 2

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 438,010

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.33 to $46.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
June 01, 2017 Filed Jun 6, 2017 00:15 UTC
Kessler JonDirector · President and CEO
Exercise / conversionCommon Stock 30,000 $1.25 $37,500.00
Disclosure

SEC source: 0001140361-17-023861 · doc1.xml · nonDerivative · entry 1

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

Read SEC document
May 15, 2017 Filed May 17, 2017 21:44 UTC
Neeleman StephenDirector · Founder and Vice Chairman
Exercise / conversionStock Option (right to buy) · Derivative 1,000 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001140361-17-021228 · doc1.xml · derivative · entry 5

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 1,000 shares

Expires 2024-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F9 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
May 15, 2017 Filed May 17, 2017 21:44 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 5,000 $45.77 $228,864.50
Disclosure

SEC source: 0001140361-17-021228 · doc1.xml · nonDerivative · entry 4

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 273,000

F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.40 to $46.02, inclusive.

F8 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

Read SEC document
May 15, 2017 Filed May 17, 2017 21:44 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 2,500 $45.77 $114,422.75
Disclosure

SEC source: 0001140361-17-021228 · doc1.xml · nonDerivative · entry 3

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 830,285

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.42 to $46.05, inclusive.

F5 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

Read SEC document
May 15, 2017 Filed May 17, 2017 21:44 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 1,000 $45.72 $45,719.00
Disclosure

SEC source: 0001140361-17-021228 · doc1.xml · nonDerivative · entry 2

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.47 to $46.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), and (7) to this Form 4.

Read SEC document
May 15, 2017 Filed May 17, 2017 21:44 UTC
Neeleman StephenDirector · Founder and Vice Chairman
Exercise / conversionCommon Stock 1,000 $14.00 $14,000.00
Disclosure

SEC source: 0001140361-17-021228 · doc1.xml · nonDerivative · entry 1

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

Read SEC document
May 01, 2017 Filed May 3, 2017 01:10 UTC
Kessler JonDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001140361-17-017978 · doc1.xml · derivative · entry 4

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,000

Underlying: Common Stock · 30,000 shares

Expires 2021-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F4 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
May 01, 2017 Filed May 3, 2017 01:10 UTC
Kessler JonDirector · President and CEO
SaleCommon Stock 4,900 $46.13 $226,057.58
Disclosure

SEC source: 0001140361-17-017978 · doc1.xml · nonDerivative · entry 3

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,000

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.99 to $46.31, inclusive.

Read SEC document
May 01, 2017 Filed May 3, 2017 01:10 UTC
Kessler JonDirector · President and CEO
SaleCommon Stock 25,100 $45.29 $1,136,819.16
Disclosure

SEC source: 0001140361-17-017978 · doc1.xml · nonDerivative · entry 2

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 424,900

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.99 to $45.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
May 01, 2017 Filed May 3, 2017 01:10 UTC
Kessler JonDirector · President and CEO
Exercise / conversionCommon Stock 30,000 $1.25 $37,500.00
Disclosure

SEC source: 0001140361-17-017978 · doc1.xml · nonDerivative · entry 1

Kessler Jon · CIK 0001615062 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016.

Read SEC document
May 01, 2017 Filed May 3, 2017 19:38 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 8,613 $46.12 $397,261.71
Disclosure

SEC source: 0001140361-17-018075 · doc1.xml · nonDerivative · entry 3

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 278,000

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

F4 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 18:54 UTC
MOTT DARCY GExecutive VP and CFO
Exercise / conversionStock Option (right to buy) · Derivative 14,000 $0.00 Strike: $0.10 $0.00
Disclosure

SEC source: 0001140361-17-016607 · doc1.xml · derivative · entry 3

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,000 shares

Expires 2018-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

F3 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 18:54 UTC
MOTT DARCY GExecutive VP and CFO
SaleCommon Stock 10,000 $43.44 $434,447.00
Disclosure

SEC source: 0001140361-17-016607 · doc1.xml · nonDerivative · entry 2

MOTT DARCY G · CIK 0001179972 · Executive VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,000

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.09 to $43.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.